 <h1>Tekamlo Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>aliskiren / amlodipine</i></p><ul class="nav-tabs nav-tabs-collapse nav-tabs-pill">
<li>Overview</li>
<li><b class="nav-item here">Side Effects</b></li>
<li>Dosage</li>
<li>Professional</li>
<li>Interactions</li>
<li class="nav-more">
More&lt;svg aria-hidden="true" class="ddc-icon ddc-icon-down" focusable="false" height="16" viewbox="0 0 24 24" width="16" xmlns="http://www.w3.org/2000/svg"&gt;&lt;path d="M18.5 7.94L19.56 9 12 16.56 4.44 9 5.5 7.94l6.5 6.5z"&gt;&lt;/path&gt;&lt;/svg&gt;
</li>
</ul><ul>
<li>Managing Side Effects</li>
</ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about aliskiren / amlodipine. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Tekamlo.</p><p><i>Applies to aliskiren/amlodipine: oral tablet</i></p><h3>Cardiovascular</h3><p>Aliskiren:</p><p><b>Rare</b> (less than 0.1%): Hypotension</p><p></p><p>Amlodipine:</p><p><b>Common</b> (1% to 10%): palpitations</p><p><b>Uncommon</b> (0.1% to 1%): Arrhythmia (including ventricular tachycardia and atrial fibrillation), bradycardia, chest pain, hypotension, peripheral ischemia, postural hypotension, tachycardia, vasculitis</p><p><b>Rare</b> (less than 0.1%): Myocardial infarction, angina<sup>[Ref]</sup></p><h3>Dermatologic</h3><p>Aliskiren:</p><p><b>Common</b> (1% to 10%): Rash</p><p><b>Rare</b> (less than 0.1%): Angioedema (involving the face, hands, or whole body)</p><p><b>Postmarketing reports</b>: Severe cutaneous adverse reactions (including Stevens Johnson syndrome and toxic epidermal necrolysis)</p><p></p><p>Amlodipine:</p><p><b>Common</b> (1% to 10%): Rash, erythematous rash</p><p><b>Uncommon</b> (0.1% to 1%): Angioedema, erythema multiforme, increased sweating, maculopapular rash, pruritus</p><p><b>Rare</b> (less than 0.1%): Alopecia, dermatitis, skin discoloration, skin dryness, urticaria, lichen planus, telangiectasia<sup>[Ref]</sup></p><h3>Endocrine</h3><p>Amlodipine:</p><p><b>Postmarketing reports</b>: Gynecomastia<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p>Aliskiren:</p><p><b>Common</b> (1% to 10%): Diarrhea, abdominal pain, dyspepsia, gastroesophageal reflux (these side effects appear to be dose related)</p><p><b>Postmarketing reports</b>: Nausea, vomiting</p><p></p><p>Amlodipine:</p><p><b>Common</b> (1% to 10%): Nausea, dysphagia, abdominal pain</p><p><b>Uncommon</b> (0.1% to 1%): Anorexia, constipation, diarrhea, dry mouth, dyspepsia, flatulence, gingival hyperplasia, pancreatitis, vomiting</p><p><b>Rare</b> (less than 0.1%): Gastritis, increased appetite, loose stools, taste perversion, dysgeusia<sup>[Ref]</sup></p><h3>Genitourinary</h3><p>Amlodipine:</p><p><b>Uncommon</b> (0.1% to 1%): Micturition disorder, micturition frequency, nocturia</p><p><b>Rare</b> (less than 0.1%): Dysuria, polyuria<sup>[Ref]</sup></p><h3>Hematologic</h3><p>Amlodipine:</p><p><b>Uncommon</b> (0.1% to 1%): Leukopenia, purpura, thrombocytopenia<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p>Aliskiren:</p><p><b>Frequency not reported</b>: Angioedema (face, hands, and body) with or without respiratory symptoms</p><p><b>Postmarketing reports</b>: Angioedema</p><p></p><p>Amlodipine:</p><p><b>Uncommon</b> (0.1% to 1%): Allergic reaction<sup>[Ref]</sup></p><h3>Hepatic</h3><p>Amlodipine:</p><p><b>Postmarketing reports</b>: Jaundice and hepatic enzyme elevations (mostly consistent with cholestasis or hepatitis)-Some cases were severe enough to require hospitalization<sup>[Ref]</sup></p><h3>Metabolic</h3><p>Aliskiren:</p><p><b>Uncommon</b> (0.1% to 1%): Elevated uric acid, gout, renal stones</p><p><b>Postmarketing reports</b>: Peripheral edema, hyponatremia</p><p></p><p>Amlodipine:</p><p><b>Uncommon</b> (0.1% to 1%): Hyperglycemia, thirst, weight loss, weight gain</p><p><b>Very rare</b> (less than 0.01%): Acute porphyria exacerbation</p><p><b>Frequency not reported</b>: New-onset diabetes<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Uncommon</b> (0.1% to 1%): Asthenia, rigors</p><p></p><p>Amlodipine:</p><p><b>Common</b> (1% to 10%): Myalgia</p><p><b>Uncommon</b> (0.1% to 1%): Arthralgia, arthrosis, muscle cramps</p><p><b>Rare</b> (less than 0.1%): Hypertonia, muscle weakness, twitching, ataxia<sup>[Ref]</sup></p><h3>Nervous system</h3><p>Aliskiren:</p><p><b>Frequency not reported</b>: Headache, dizziness, fatigue, episodes of tonic-clonic seizures with loss of consciousness</p><p></p><p>Amlodipine:</p><p><b>Common</b> (1% to 10%): Headache, dizziness, somnolence</p><p><b>Uncommon</b> (0.1% to 1%): Hypoesthesia, paresthesia, peripheral neuropathy, postural dizziness, syncope, tinnitus, tremor</p><p><b>Rare</b> (less than 0.1%): Migraine<sup>[Ref]</sup></p><h3>Ocular</h3><p>Amlodipine:</p><p><b>Uncommon</b> (0.1% to 1%): Abnormal vision, conjunctivitis, diplopia, eye pain</p><p><b>Rare</b> (less than 0.1%): Abnormal visual accommodation, xerophthalmia<sup>[Ref]</sup></p><h3>Psychiatric</h3><p>Amlodipine: </p><p><b>Rare</b> (less than 0.1%): Abnormal dreams, anxiety, depersonalization, depression, insomnia, nervousness, agitation, amnesia, apathy<sup>[Ref]</sup></p><h3>Renal</h3><p>Amlodipine:</p><p><b>Rare</b> (less than 0.1%): Interstitial nephritis<sup>[Ref]</sup></p><h3>Respiratory</h3><p>Aliskiren:</p><p><b>Frequency not reported</b>: Nasopharyngitis, upper respiratory tract infection, cough</p><p></p><p>Amlodipine:</p><p><b>Common</b> (1% to 10%): Epistaxis</p><p><b>Uncommon</b> (0.1% to 1%): Dyspnea</p><p><b>Rare</b> (less than 0.1%): Coughing, rhinitis</p><p><b>Postmarketing reports</b>: Pulmonary edema was reported during a study of patients with NYHA Class III or IV heart failure without clinical symptoms or objective evidence of underlying ischemic disease.<sup>[Ref]</sup></p><h3>Other</h3><p><b>Rare</b> (less than 0.1%): Parosmia</p><p><b>Frequency not reported</b>: Tinnitus<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Tekamlo (aliskiren-amlodipine)." Novartis Pharmaceuticals, East Hanover, NJ. </p><h2>More about Tekamlo (aliskiren / amlodipine)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Drug class: miscellaneous antihypertensive combinations</li>
<li>FDA Alerts (1)</li>
<li>FDA Approval History</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Tekamlo &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>High Blood Pressure</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>